Clinical bottom line
Uterine arteriovenous malformations (AVMs) are rare but potentially life-threatening vascular anomalies that can cause severe uterine bleeding. Advances in imaging modalities, particularly transvaginal color Doppler ultrasound and magnetic resonance angiography (MRA), have improved noninvasive diagnosis. Management strategies have evolved from primarily surgical interventions toward minimally invasive uterine artery embolization (UAE), which offers effective hemorrhage control while preserving fertility in many cases. However, treatment must be individualized based on symptom severity, lesion size and location, and patient reproductive desires. Current evidence supports UAE as first-line therapy for symptomatic uterine AVMs, with surgery reserved for refractory cases or when embolization is contraindicated.
What the evidence shows
Uterine AVMs are abnormal direct connections between uterine arteries and veins without an intervening capillary bed, often acquired after trauma, pregnancy-related events, or uterine procedures. They can present with sudden, heavy vaginal bleeding, sometimes leading to hemodynamic instability. Early recognition is critical to prevent morbidity.
**Diagnosis:** Transvaginal color Doppler ultrasound is the initial imaging modality of choice due to its accessibility and ability to detect high-velocity, low-resistance flow characteristic of AVMs. Sensitivity and specificity are enhanced when combined with spectral Doppler analysis [1]. Magnetic resonance angiography (MRA) and computed tomography angiography (CTA) provide detailed vascular mapping and are useful in complex or equivocal cases [2]. Digital subtraction angiography (DSA) remains the gold standard for definitive diagnosis and therapeutic planning but is invasive.
**Treatment:** Historically, hysterectomy was the mainstay for severe or recurrent bleeding from uterine AVMs. However, uterine artery embolization (UAE) has emerged as a safe and effective minimally invasive alternative that preserves the uterus and fertility potential. A systematic review and meta-analysis (2020) including over 200 patients reported UAE success rates exceeding 90% in controlling hemorrhage, with low complication rates and favorable reproductive outcomes [3]. Embolic agents such as polyvinyl alcohol particles, coils, or glue are used depending on lesion characteristics.
Conservative management with observation may be appropriate in asymptomatic or minimally symptomatic patients, as some AVMs regress spontaneously. Medical therapies (e.g., hormonal agents) have limited evidence and are generally adjunctive.
Caveats and uncertainty
The rarity of uterine AVMs limits large randomized controlled trials, so much evidence derives from case series and retrospective cohorts, introducing potential bias. Variability in embolization techniques and embolic materials complicates direct comparisons. Long-term fertility outcomes post-UAE require further prospective study, although current data are encouraging.
Differential diagnosis includes retained products of conception and gestational trophoblastic disease, which can mimic AVMs on imaging, necessitating careful clinical correlation and sometimes histopathology.
In rare cases, embolization may fail or be contraindicated due to vascular anatomy or patient comorbidities, requiring surgical intervention. The risk of uterine necrosis or non-target embolization, although low, should be considered.
How this may change practice
Clinicians should maintain a high index of suspicion for uterine AVMs in women presenting with unexplained heavy uterine bleeding, especially with a history of uterine instrumentation or pregnancy-related events. Early use of transvaginal color Doppler ultrasound can facilitate prompt diagnosis.
UAE should be considered the first-line treatment for symptomatic uterine AVMs, offering a uterus-sparing option with high efficacy and safety. Multidisciplinary collaboration with interventional radiology is essential for optimal management.
Patient counseling should address the benefits and risks of embolization versus surgery, including potential impacts on fertility and pregnancy outcomes. Conservative management may be appropriate in select asymptomatic cases with close monitoring.
Ongoing research and registries are needed to refine embolization protocols and better characterize long-term reproductive outcomes.